id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8978 R30432 |
Coste (Lamotrigine) (Controls unexposed NOS) (Mixed indications), 2020 | Weight at birth <2500 g | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No | 1.15 [0.99;1.35] C | 172/2,813 91,172/1,707,707 | 91,344 | 2,813 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8974 R30418 |
Hernández-Díaz (Lamotrigine) (Mixed indications), 2014 | Low birth weight (< 2500g) | throughout pregnancy | prospective cohort | unexposed, disease free | Adjustment: No | 1.20 [0.71;2.03] C | 74/1,581 18/457 | 92 | 1,581 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8975 R30420 |
Kilic (Lamotrigine) (Controls unexposed NOS) (Mixed indications), 2014 | Low birth weight (< 2500 g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) excluded | Adjustment: Yes |
1.30 [1.00;1.80] excluded (control group) |
48/876 23,503/673,844 | 23,551 | 876 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8976 R30423 |
Kilic (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2014 | Low birth weight (< 2500 g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: No Controls: epilepsy indication | 1.17 [0.85;1.61] C | 48/876 249/5,275 | 297 | 876 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8902 R30063 |
Artama (Lamotrigine) (Controls unexposed, disease free), 2013 | Low birth weight (< 2500g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
0.99 [0.43;2.25] excluded (control group) |
6/173 21,546/719,509 | 21,552 | 173 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8903 R30075 |
Artama (Lamotrigine) (Controls unexposed, sick), 2013 | Low birth weight (< 2500g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 0.96 [0.39;2.34] | 6/173 65/1,793 | 71 | 173 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8953 R30312 |
Veiby (Lamotrigine) (Controls unexposed, disease free) b, 2013 | Low birth weight (< 2500 grams) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: Yes |
1.20 [0.50;2.80] excluded (control group) |
6/103 5,024/106,899 | 5,030 | 103 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8954 R30326 |
Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 | Low birth weight (< 2500 grams) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 1.43 [0.55;3.75] C | 6/103 16/386 | 22 | 103 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 5 studies | 1.16 [1.02;1.32] | 91,826 | 5,546 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Lamotrigine) (Controls unexposed NOS) (Mixed indications; 2: Lamotrigine) (Mixed indications; 3: Lamotrigine) (Controls unexposed, sick) (Mixed indications; 4: Lamotrigine) (Controls unexposed, sick; 5: Lamotrigine) (Controls unexposed, sick) ;
Asymetry test p-value = 0.8022 (by Egger's regression)
slope=0.1398 (0.0394); intercept=0.0718 (0.2624); t=0.2735; p=0.8022
excluded 8902, 8953, 8975